About EAP

European Academy of Paediatrics

The European Academy of Paediatrics (EAP) is the united voice of European Paediatrics and Child Health, representing 53 national paediatric societies across Europe and 14 European paediatric subspecialty societies, with close collaboration to a further 14 affiliated societies dedicated to Child Health.

Our Vision and Mission

The European Academy of Paediatrics exists to promote the health of children and young people in Europe. It aims to improve standards in training, service and research and to represent the professional interests of paediatricians in the EU. It closely collaborates with the European Union of Medical Specialists and therefore has influence in the political arena to advocate for children and young people as well as for the profession.

Our Members

53 National Societies
EAP Represents national paediatric societies across Europe, with official representatives nominated as National Delegates from each society.
15 affiliated societies
15 affiliated societies dedicated to Child Health, including ESPNIC, UNEPSA/EPA, IPA, ESPR, and more...
14 subspecialty societies
UEMS Subspecialty Societies Neonatology, Allergology, Emergency Medicine, and more...
National Delegates
Each country can elect up to 2 National Delegates, representing their respective societies and countries at the EAP Council
Young EAP
Young EAP is the network of national junior paediatric representatives within the EAP. Up to 2 non-voting, official representatives are elected per country.
Individual Members
Individual members of a national paediatric organisation which is a full member of EAP, are by default, without any subscription fee, non-voting individual members of EAP.
Affiliated Individual Members
Open to all nationalities (non-European). Including board-certified paediatricians/specialists in paediatrics (or equivalent) or any other physician or scientist with a special interest in paediatrics.

Partnerships

EAP values partnerships that align with its mission and values while maintaining its independence in decision-making, policy development, and annual planning. Economic support from partners must not influence EAP’s principles or restrict its ability to address issues objectively and transparently.
 

Partnerships are established with organisations whose views and practices are consistent with EAP’s values. These collaborations must uphold mutual respect, trust, and clearly defined principles, ensuring EAP’s core integrity remains uncompromised.

 

All partnerships are transparently disclosed, and EAP remains accountable to its members and the public, demonstrating that no undue influence affects its policies or practices.

EAP Guiding Principles

European Academy of Paediatrics (EAP) Adopts The Following Guiding Principles

EAP’s guiding principles with regard to partnerships, sponsorship and conflicts of interest aim to increase EAP’s potential to access funds, services in kind and joint venture operations from public bodies, firms or foundations in ways that do not contravene the principles and values of EAP and its members.

It does not aim to provide a definition of every possible funding opportunity or relationship but rather define a set of operating principles.

The guiding principles comply with the objectives and mission of EAP: The European Academy of Paediatrics exists to promote the health of children and young people in Europe.

EAP is a not-for-profit and non-governmental Association that intends to maintain a high level of independence and integrity. This will allow EAP to position itself in public health and health care policy without being influenced by vested interests.

Sponsorship

The following applies to all sources of financing.

EAP shall accept funding from organisations that hold views and practices that are not contrary to EAP’s mission and values.

EAP will only accept funding that does not compromise its core principles and does not restrict its ability to address relevant issues freely, thoroughly and objectively in private and public forums.

EAP will not accept funding from organisations engaged in the manufacture and/or marketing of commercial products whose sale is against EAP’s mission (for example: tobacco, alcohol, arms, unhealthy food, etc).

 

Funding from public sources may be directed at EAP’s core functions or specific projects or activities. Core functions concern the Private sponsorship can only take the form of financial support for specific projects or activities.

 

Grants of this kind shall be unrestricted and unconditional. When financial support is approved, a contract or memorandum of understanding between EAP and the organisation will be agreed and signed by authorised parties detailing length of time for the agreement, contribution value, joint activities and deliverables to be achieved, with a start and end date. This agreement will ensure that no restrictions or conditions are imposed by the sponsors which would affect the content of the project and/ or activities.

 

Private sponsorship can only take the form of financial support for specific projects or activities. Grants of this kind shall be unrestricted and unconditional. When financial support is approved, a contract or memorandum of understanding between EAP and the organisation will be agreed and signed by authorised parties detailing length of time for the agreement, contribution value, joint activities and deliverables to be achieved, with a start and end date. This agreement will ensure that no restrictions or conditions are imposed by the sponsors which would affect the content of the project and/ or activities.

 

EAP should always be able to prove to its members and the public that the sponsorship does not exert any influence on its own policies and practices. EAP will ensure that its independence and integrity are preserved in any financial relationship with another organisation.

In order to avoid the risk of being identified with one single vested interest, EAP aims to diversify the sources of funding as much as possible.

Corporate partners or private sponsors shall at no time make use of the name, or logo of EAP, or make any claim of association with EAP without EAP’s prior agreement.

Procedure for partnership and sponsorship agreements

Partnership and sponsorship opportunities will be assessed by EAP’s Executive Committee on a case by case basis, while respecting the above mentioned principles. The conclusions of their assessment will be circulated amongst EAP members.

When approached by, or when approaching, an organisation/agency for funding, EAP will request information about the organisation, including their principal activities, their products or services. EAP will also undertake its own research about the organisation/agency, notably about the nature of the organisation; the nature of its products; the sources of its product; the means used to promote the product, or the consequences of these processes.

When financial support is approved, a contract or memorandum of understanding between EAP and the organisation will be agreed and signed by authorised parties detailing length of time for the agreement, contribution value, joint activities and deliverables to be achieved, with a start and end date.

When weighing up whether or not to accept funding from commercial organisations/ agencies, grant making bodies or individuals, the following should be considered: the nature of the organisation; the nature of its products; the sources of its product; the means used to promote the product, or the consequences of these processes, and whether these are compatible with the principles outlined in the present document.

Any financial support by commercial companies will appear in EAP’s reports to members and the public and other relevant documents.

Conflict of interests of the Executive Committee and its members

The Executive Committee is responsible for the strategic directions, the setting of priorities and the programming of EAP’s activities, including the determination of the annual work program. Also, the Executive Committee members assist in fundraising and representation activities.

 

Members of the Executive Committee shall therefore declare, annually, any interest and function, be it corporate or institutional and declare any (potential) conflict of interest which may arise throughout the duration of their service on the Executive Committee.

close menu icon

Your Enquiries Are Welcome

We will respond to you by Email

Core-MD Project

Coordinating Research and Evidence for Medical Devices (CORE-MD)

New ways to test high-risk medical devices.

 

Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.


It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.

EAP Representative:

  • BERTHOLD KOLETZKO
Read more